Black Diamond Therapeutics (BDTX) Shares Outstanding (Diluted Average): 2020-2021
Historic Shares Outstanding (Diluted Average) for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to $36.2 million.
- Black Diamond Therapeutics' Shares Outstanding (Diluted Average) rose 0.81% to $36.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $36.2 million, marking a year-over-year increase of 0.81%. This contributed to the annual value of $32.9 million for FY2020, which is N/A change from last year.
- According to the latest figures from Q3 2021, Black Diamond Therapeutics' Shares Outstanding (Diluted Average) is $36.2 million, which was up 0.10% from $36.2 million recorded in Q2 2021.
- Over the past 5 years, Black Diamond Therapeutics' Shares Outstanding (Diluted Average) peaked at $36.2 million during Q3 2021, and registered a low of $23.7 million during Q1 2020.
- Moreover, its 2-year median value for Shares Outstanding (Diluted Average) was $35.9 million (2020), whereas its average is $33.9 million.
- Data for Black Diamond Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 52.42% (in 2021) over the last 5 years.
- Quarterly analysis of 2 years shows Black Diamond Therapeutics' Shares Outstanding (Diluted Average) stood at $32.9 million in 2020, then grew by 0.81% to $36.2 million in 2021.
- Its Shares Outstanding (Diluted Average) stands at $36.2 million for Q3 2021, versus $36.2 million for Q2 2021 and $36.1 million for Q1 2021.